17:12:49Canada

AngioDynamics, Inc. (ANGO)

NASDAQ

Key stats Fiscal year 2026

Income statement

Revenue
320,174,000 9.5%
Net income
-36,742,000
Gross profit
174,892,000
Operating income
-39,927,000
Earnings per share
-0.88
R&D expense
29,447,000

Growth and profitability

Gross margin
54.62
Operating margin
-12.47
Net margin
-11.48
Return on equity
-21.51
Return on assets
-13.75
Free cash flow margin
0.16

Balance sheet

Total assets
267,163,000
Total liabilities
96,338,000
Shareholders' equity
170,825,000
Cash and equivalents
53,864,000
Current ratio
2.19

Cash flow and ratios

Operating cash flow
3,089,000
Free cash flow
508,000

Shareholder returns

Share buybacks
0
Shares outstanding
42,054,450
Book value per share
4.06
Revenue and net income
From revenue to profit 2026
Debt, free cash flow and cash
Earnings per share

Company information

Headquarters
Latham, NY
Exchange
NASDAQ
Fiscal year end
05-31
Industry (SEC)
Surgical & Medical Instruments & Apparatus

Fiscal year end: · Source: SEC EDGAR

AngioDynamics, Inc. trades on NASDAQ under the ticker symbol ANGO. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis